Unknown

Dataset Information

0

Determining the Best Immunization Strategy for Protecting African Children Against Invasive Salmonella Disease.


ABSTRACT: Background:The World Health Organization recently prequalified a typhoid conjugate vaccine (TCV), recommending its use in persons ?6 months to 45 years residing in typhoid fever (TF)-endemic areas. We now need to consider how TCVs can have the greatest impact in the most vulnerable populations. Methods:The Typhoid Fever Surveillance in Africa Program (TSAP) was a blood culture-based surveillance of febrile patients from defined populations presenting at healthcare facilities in 10 African countries. TF and invasive non-typhoidal Salmonella (iNTS) disease incidences were estimated for 0-10 year-olds in one-year age increments. Results:Salmonella Typhi and iNTS were the most frequently isolated pathogens; 135 and 94 cases were identified, respectively. Analysis from three countries was excluded (incomplete person-years of observation (PYO) data). Thirty-seven of 123 TF cases (30.1%) and 71/90 iNTS disease cases (78.9%) occurred in children aged <5 years. No TF and 8/90 iNTS infections (8.9%) were observed in infants aged <9 months. The TF incidences (/100 000 PYO) for children aged <1 year and 1 to <2 years were 5 and 39, respectively; the highest incidence was 304 per 100 000 PYO in 4 to <5 year-olds. The iNTS disease incidence in the defined age groups ranged between 81 and 233 per 100 000 PYO, highest in 1 to <2 year-olds. TF and iNTS disease incidences were higher in West Africa. Conclusions:High burden of TF detected in young children strengthens the need for TCV introduction. Given the concurrent iNTS disease burden, development of a trivalent vaccine against S. Typhi, S. Typhimurium, and S. Enteritidis may be timely in this region.

SUBMITTER: Jeon HJ 

PROVIDER: S-EPMC6260167 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Determining the Best Immunization Strategy for Protecting African Children Against Invasive Salmonella Disease.

Jeon Hyon Jin HJ   Pak Gi Deok GD   Im Justin J   Owusu-Dabo Ellis E   Adu-Sarkodie Yaw Y   Gassama Sow Amy A   Bassiahi Soura Abdramane A   Gasmelseed Nagla N   Keddy Karen H KH   Bjerregaard-Andersen Morten M   Konings Frank F   Aseffa Abraham A   Crump John A JA   Chon Yun Y   Breiman Robert F RF   Park Se Eun SE   Cruz Espinoza Ligia Maria LM   Seo Hye Jin HJ   May Jürgen J   Meyer Christian G CG   Andrews Jason R JR   Panzner Ursula U   von Kalckreuth Vera V   Wierzba Thomas F TF   Rakotozandrindrainy Raphaël R   Dougan Gordon G   Levine Myron M MM   Hombach Joachim J   Kim Jerome H JH   Clemens John D JD   Baker Stephen S   Marks Florian F  

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20181101 12


<h4>Background</h4>The World Health Organization recently prequalified a typhoid conjugate vaccine (TCV), recommending its use in persons ≥6 months to 45 years residing in typhoid fever (TF)-endemic areas. We now need to consider how TCVs can have the greatest impact in the most vulnerable populations.<h4>Methods</h4>The Typhoid Fever Surveillance in Africa Program (TSAP) was a blood culture-based surveillance of febrile patients from defined populations presenting at healthcare facilities in 10  ...[more]

Similar Datasets

| S-EPMC4333450 | biostudies-literature
| S-EPMC4933780 | biostudies-literature
| S-EPMC5215422 | biostudies-other
| S-EPMC5167260 | biostudies-literature
| S-EPMC7218524 | biostudies-literature
| S-EPMC8425702 | biostudies-literature
| PRJEB29947 | ENA
| S-EPMC6157060 | biostudies-literature
| S-EPMC4249112 | biostudies-literature
| S-EPMC5844948 | biostudies-literature